Human Subject Research
NEWS: Effective July 27, 2015 SPARCS IRB will be used for all new IRB protocol submissions. Paper forms for new protocols will not be accepted. See details at SPARCS Roll-out.
The Carnegie Mellon University Institutional Review Board (IRB)
All research involving the use of human research subjects (participants) must be reviewed and approved by the CMU Institutional Review Board (IRB) before the research can be initiated.
- Research means a systematic investigation including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge; (see 45 CFR 46.102(d)).
- Human Subject means a living individual about whom an investigator (whether professional or student) conducting research obtains (1) data through intervention or interaction with the individual, or (2) identifiable private information. (see 45 CFR 46.102(f)).
The primary responsibility of the IRB is to assure that appropriate steps are taken to protect the rights and welfare of humans participating in research. The IRB functions according to the guidelines of the Office of Human Research Protection (OHRP) and other federal regulatory agencies. The IRB is a committee with representation from CMU faculty and the community. The CMU IRB meets on the first Tuesday of every month. Protocols that are eligible for Exempt and Expedited Review are processed on an ongoing basis.